Using an epigenetic mechanism, romidepsin restored gene expression and alleviated social deficits in animal model of autism
Of all the challenges that come with a diagnosis of autism spectrum disorder (ASD), the social difficulties are among the most devastating. Currently, there is no treatment for this primary symptom of ASD. New research at the University at Buffalo reveals the first evidence that it may be possible to use a single compound to alleviate the behavioral symptoms by targeting sets of genes involved in the disease.
The research, published today in Nature Neuroscience, demonstrated that brief treatment with a very low dose of romidepsin, a Food and Drug Administration-approved anti-cancer drug, restored social deficits in animal models of autism in a sustained fashion.
The three-day treatment reversed social deficits in mice deficient in a gene called Shank 3, an important risk factor for ASD. This effect lasted for three weeks, spanning the juvenile to late adolescent period, a critical developmental stage for social and communication skills. That is equivalent to several years in humans, suggesting the effects of a similar treatment could potentially be long-lasting, the researchers say.
Profound, prolonged effect
“We have discovered a small molecule compound that shows a profound and prolonged effect on autism-like social deficits without obvious side effects, while many currently used compounds for treating a variety of psychiatric diseases have failed to exhibit the therapeutic efficacy for this core symptom of autism,” said Zhen Yan, PhD, professor in the Department of Physiology and Biophysics in the Jacobs School of Medicine and Biomedical Sciences at UB, and senior author on the paper.
The study builds on her previous research from 2015. That work revealed how the loss of Shank 3 disrupts neuronal communications by affecting the function of the NMDA (n-methyl-D-aspartate) receptor, a critical player in regulating cognition and emotion, leading to deficits in social preference that are common in ASD.
In the new research, the UB scientists found they could reverse those social deficits with a very low dose of romidepsin, which, they found, restores gene expression and function using an epigenetic mechanism, where gene changes are caused by influences other than DNA sequences. Yan noted that human genetics studies have suggested that epigenetic abnormalities likely play a major role in ASD.
To pursue these promising findings, Yan has founded a startup company called ASDDR, which was awarded a Small Business Technology Transfer grant from the National Institutes of Health last summer for more than $770,000.
Epigenetics in ASD
Many of the mutations in ASD, Yan explained, result from chromatin remodeling factors, which are involved in dynamically changing the structure of chromatin, the complex of genetic material in the cell nucleus that condenses into chromosomes.
“The extensive overlap in risk genes for autism and cancer, many of which are chromatin remodeling factors, supports the idea of repurposing epigenetic drugs used in cancer treatment as targeted treatments for autism,” said Yan.
She and her colleagues knew that chromatin regulators — which control how genetic material gains access to a cell’s transcriptional machinery — were key to treating the social deficits in ASD, but the challenge was to know how to affect key risk factors at once.
“Autism involves the loss of so many genes,” Yan explained. “To rescue the social deficits, a compound has to affect a number of genes that are involved in neuronal communication.”
To do so, the team turned to a type of chromatin remodeler called histone modifiers. They modify proteins called histones that help organize genetic material in the nucleus so gene expression can be regulated. Since many genes are altered in autism, the UB scientists knew a histone modifier might be effective.
Loosening up chromatin
In particular, they were interested in histone deacetylase (HDAC), a family of histone modifiers that are critically involved in the remodeling of chromatin structure and the transcriptional regulation of targeted genes.
“In the autism model, HDAC2 is abnormally high, which makes the chromatin in the nucleus very tight, preventing genetic material from accessing the transcriptional machinery it needs to be expressed,” said Yan. “Once HDAC2 is upregulated, it diminishes genes that should not be suppressed, and leads to behavioral changes, such as the autism-like social deficits.”
But the anti-cancer drug romidepsin, a highly potent HDAC inhibitor, turned down the effects of HDAC2, allowing genes involved in neuronal signaling to be expressed normally.
“The HDAC inhibitor loosens up the densely packed chromatin so that the transcriptional machinery gains access to the promoter area of the genes; thus they can be expressed,” Yan said.
The rescue effect on gene expression was widespread. When Yan and her co-authors conducted genome-wide screening at the Genomics and Bioinformatics Core at UB’s New York State Center of Excellence in Bioinformatics and Life Sciences, they found that romidepsin restored the majority of the more than 200 genes that were suppressed in the autism animal model they used.
“The advantage of being able to adjust a set of genes identified as key autism risk factors may explain the strong and long-lasting efficacy of this therapeutic agent for autism,” Yan explained. She and her colleagues will continue their focus on discovering and developing better therapeutic agents for autism.
The Latest on: Autism
Autism Awareness Day at Clark Preschool
on April 18, 2018 at 12:13 pm
On Wednesday, April 11, the Clark Preschool "Lit It Up Blue" by wearing blue in celebration of the Clark School District's Autism Awareness Day. Students from both elementary schools and the high school visited the preschool to participate in the day's events. […]
15-Year-Old Boy with Autism Builds World's Largest Titanic Lego Replica
on April 18, 2018 at 9:25 am
15-year-old Brynjar Karl, who has autism, certainly has a lot to be proud of. He completed building the world’s largest Titanic model at just ten-years-old. Radio.com 1:11 […]
Stoughton's Katie Walter advocates on and off the court for herself and autism awareness
on April 18, 2018 at 8:45 am
STOUGHTON — One of Katie Walter’s strengths is as an advocate for herself and autism awareness. A defensive specialist for the Vikings’ junior varsity volleyball team last fall, Walter started a match for the varsity and received a standing ovation ... […]
"A Look Inside an Autism-Friendly Workplace and Culture"
on April 18, 2018 at 7:28 am
Last week, I was in New York and had the opportunity morning to tour a true “autism-friendly workplace”—one that differs not only from most workplaces today but also from most workplaces that describe themselves as autism-friendly. I think you’ll ... […]
Researchers look to Chicago families to help trace the roots of autism
on April 18, 2018 at 5:38 am
Chicago researchers are spearheading efforts to find the complex biological underpinnings of autism — a brain disorder that affects one in 68 American children. The work, aimed at developing drugs and other targeted, personalized treatments, is underway ... […]
My Autism Makes Me Different, not Less
on April 17, 2018 at 5:34 pm
I am autistic, but autism doesn’t define me. My social difficulties don’t mean I can’t have friends. My lack of eye contact doesn’t mean I don’t care. I’m not a picky eater, I just struggle with food. I’m not melting down for attention; I’m ... […]
Life is My Classroom - Autism and Business
on April 17, 2018 at 11:04 am
Almost 16 years ago our second beautiful baby boy was brought into the world. Along the way I became a better father, leader and human. Watching him grow from potato into wee little toddler was amazing. The glimmer in his eyes, that smile, the laughter. […]
Boy with autism builds world's largest Titanic replica with Legos: 'The whole process helped me out of the fog'
on April 17, 2018 at 9:20 am
A now 15-year-old boy from Iceland used 56,000 Legos to build a replica of one of the world’s most famous ships: the Titanic. Brynjar Karl Bigisson, from Reykjavik, the country’s capital, built the model when he was just 10 years old. It has since been ... […]
Mom Started Business For Son With Autism. Now She Employs 20 Like Him.
on April 16, 2018 at 12:13 pm
When her husband suddenly died in 2010, Stella Spanakos felt uncertain about what the future would hold for Nicholas, their son. Nicholas has autism, and this inspired Spanakos to think of a job he could be good at. She opened up a company that could ... […]
Boy with autism builds world's largest Lego Titanic replica
on April 16, 2018 at 1:17 am
(CNN)The world's largest Lego replica of the doomed Titanic liner was built over 700 hours -- 11 months -- by a 10-year-old boy from Reykjavik, Iceland, who is on the autism spectrum. It will make its American debut Monday at the Titanic Museum Attraction ... […]
via Google News and Bing News